B. Riley Securities reiterated coverage on Mustang Bio with a new price target

1/24/22 8:55:18 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

B. Riley Securities reiterated coverage of Mustang Bio with a rating of Buy and set a new price target of $6.00 from $13.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$MBIO

Date	Price Target	Rating	Analyst
1/24/2022	$13.00 → $6.00	Buy	B. Riley Securities